[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Morozov et al., 2018 - Google Patents

Human milk oligosaccharides as promising antivirals

Morozov et al., 2018

Document ID
766304454171139756
Author
Morozov V
Hansman G
Hanisch F
Schroten H
Kunz C
Publication year
Publication venue
Molecular nutrition & food research

External Links

Snippet

Human milk oligosaccharides (HMOs) are diverse unconjugated carbohydrates that are highly abundant in human breast milk. These glycans are investigated in the context of exhibiting multiple functions in infant growth and development. They seem to provide …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Similar Documents

Publication Publication Date Title
Morozov et al. Human milk oligosaccharides as promising antivirals
Moore et al. Prospecting human milk oligosaccharides as a defense against viral infections
Ramani et al. Epidemiology of human noroviruses and updates on vaccine development
Wiciński et al. Human milk oligosaccharides: health benefits, potential applications in infant formulas, and pharmacology
Liu et al. A carbohydrate-binding protein from the edible lablab beans effectively blocks the infections of influenza viruses and SARS-CoV-2
Yi et al. Enterovirus 71 infection and vaccines
Ströh et al. Glycan engagement by viruses: receptor switches and specificity
KR102065575B1 (en) A conjugate including a core and sialic acids, sialyllactoses or derivatives thereof bound to the surface of the core and use thereof
Stencel-Baerenwald et al. The sweet spot: defining virus–sialic acid interactions
Etzold et al. Glycan-dependent viral infection in infants and the role of human milk oligosaccharides
Schroten et al. Human norovirus interactions with histo-blood group antigens and human milk oligosaccharides
Ruvoën‐Clouet et al. Noroviruses and histo‐blood groups: the impact of common host genetic polymorphisms on virus transmission and evolution
Hansman et al. Structural basis for norovirus inhibition and fucose mimicry by citrate
Böhm et al. Revisiting the role of histo-blood group antigens in rotavirus host-cell invasion
Caddy et al. Genogroup IV and VI canine noroviruses interact with histo-blood group antigens
JP6441821B2 (en) Synthetic or recombinant fucosylated oligosaccharides for the treatment of infectious diseases
Idris et al. Glycosylation of dengue virus glycoproteins and their interactions with carbohydrate receptors: possible targets for antiviral therapy
Gao et al. Antiviral effects of human milk oligosaccharides: A review
US11331329B2 (en) Fucosylated oligosaccharides for prevention of coronavirus infection
Ruoff et al. Structural basis of nanobodies targeting the prototype norovirus
Ali et al. Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens
Sun et al. Structural basis of glycan recognition of rotavirus
Taouai et al. Unprecedented thiacalixarene fucoclusters as strong inhibitors of ebola cis-cell infection and hcmv-gb glycoprotein/DC-SIGN c-type lectin interaction
Liu et al. Sodium copper chlorophyllin is highly effective against enterovirus (EV) A71 infection by blocking its entry into the host cell
Chen et al. Recent Progress in Human Milk Oligosaccharides and Its Antiviral Efficacy